K. Higaki

A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer

N. Masuda, N. Masuda, S. Morita, 2014, Cancer Chemotherapy and Pharmacology.